0001161697-22-000338.txt : 20220705 0001161697-22-000338.hdr.sgml : 20220705 20220705181307 ACCESSION NUMBER: 0001161697-22-000338 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220705 DATE AS OF CHANGE: 20220705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLETCHER R JOHN CENTRAL INDEX KEY: 0001215024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39086 FILM NUMBER: 221066791 MAIL ADDRESS: STREET 1: C/O VYANT BIO, INC. STREET 2: 201 ROUTE 17 NORTH, 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KORU Medical Systems, Inc. CENTRAL INDEX KEY: 0000704440 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 133044880 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE DRIVE CITY: MAHWAH STATE: NJ ZIP: 07430 BUSINESS PHONE: 845-469-2042 MAIL ADDRESS: STREET 1: 100 CORPORATE DRIVE CITY: MAHWAH STATE: NJ ZIP: 07430 FORMER COMPANY: FORMER CONFORMED NAME: REPRO MED SYSTEMS INC DATE OF NAME CHANGE: 19920703 4 1 form_4.xml FORM 4 FOR 06-30-2022 X0306 4 2022-06-30 0 0000704440 KORU Medical Systems, Inc. KRMD 0001215024 FLETCHER R JOHN C/O KORU MEDICAL SYSTEMS, INC. 100 CORPORATE DRIVE MAHWAH NJ 07430 1 0 0 1 Chairman of the Board Common Stock 2022-06-30 4 A 0 9003 2.50 A 118963 D The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney filed herewith as Exhibit 24. /s/ Stephen Unger- Attorney-in-Fact 2022-07-05 EX-24 2 ex_24.htm POWER OF ATTORNEY

 

EXHIBIT 24 TO FORM 4

 

POWER OF ATTORNEY

 

Know all by these presents, that the undersigned hereby constitutes and appoints each of Linda Tharby and Stephen Unger and their successors in office and designees, signing singly, the undersigned’s true and lawful attorney-in-fact to:

 

  (1) execute and file for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Repro Med Systems, Inc.(the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
     
  (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
     
  (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this __23__ day of June, 2022.

 

/s/ R. John Fletcher

(Signature)

 

R. John Fletcher

(Printed Name)